Hohimer Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Hohimer Wealth Management, LLC

$419 Million
Q1 2024

A detailed history of Hohimer Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hohimer Wealth Management, LLC holds 51,378 shares of GILD stock, worth $3.53 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

51,378

Previous 51,778 0.77%

Holding current value

$3.53 Million

Previous $4.19 Million 10.28%

% of portfolio

0.9%

Previous 1.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $28,632 - $34,916	-400 Reduced 0.77%	51,378 $3.76 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $35,316 - $40,049	482 Added 0.94%	51,778 $4.19 Million
Q3 2023 Nov 20, 2023	SELL	$73.94 - $80.67 $95,308 - $103,983	-1,289 Reduced 2.45%	51,296 $3.84 Million
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $144,419 - $164,730	-1,900 Reduced 3.49%	52,585 $4.05 Million
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $114,032 - $129,918	-1,475 Reduced 2.64%	54,485 $4.52 Million

Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $32,032 - $45,987	-514 Reduced 0.91%	55,960 $4.8 Million
Q3 2022 Nov 02, 2022	BUY	$59.54 - $68.01 $47,393 - $54,135	796 Added 1.43%	56,474 $3.48 Million
Q2 2022 Jul 25, 2022	SELL	$57.72 - $65.01 $162,712 - $183,263	-2,819 Reduced 4.82%	55,678 $3.44 Million
Q1 2022 May 03, 2022	BUY	$57.92 - $72.58 $228,146 - $285,892	3,939 Added 7.22%	58,497 $3.48 Million
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $401,023 - $455,168	-6,181 Reduced 10.18%	54,558 $3.96 Million
Q3 2021 Oct 18, 2021	BUY	$67.69 - $73.03 $39,327 - $42,430	581 Added 0.97%	60,739 $4.24 Million
Q2 2021 Jul 12, 2021	BUY	$63.47 - $69.35 $251,975 - $275,319	3,970 Added 7.07%	60,158 $4.14 Million
Q1 2021 Apr 12, 2021	BUY	$60.0 - $68.46 $282,120 - $321,898	4,702 Added 9.13%	56,188 $3.63 Million
Q4 2020 Jan 11, 2021	BUY	$56.65 - $64.55 $1.56 Million - $1.77 Million	27,491 Added 114.57%	51,486 $3 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $46,140 - $58,013	-743 Reduced 3.0%	23,995 $1.45 Million
Q2 2020 Jul 14, 2020	SELL	$72.34 - $84.0 $576,477 - $669,396	-7,969 Reduced 24.36%	24,738 $1.9 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $256,970 - $329,142	4,103 Added 14.34%	32,707 $2.61 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.76 Million - $1.94 Million	28,604 New	28,604 $1.86 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hohimer Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hohimer Wealth Management, LLC with notifications on news.

Account

Hohimer Wealth Management, LLC Gilead Sciences, Inc. Transaction History